Is Pacific Edge (ASX: PEB) an ASX Healthcare Stock Worth Following? - Kalkine
Is Pacific Edge (ASX: PEB) an ASX Healthcare Stock Worth Following? Kalkine
Latest articles and price-sensitive announcements with AI sentiment classification.
Is Pacific Edge (ASX: PEB) an ASX Healthcare Stock Worth Following? Kalkine
other announcement
other announcement
other announcement
Highlights Pacific Edge secured a major US Medicare-related breakthrough tied to cancer diagnostics. The development strengthened discussion around the company’s profitability pathway. Global healthcare diagnostics demand continues lifting attention on precision medicine businesses. Pacific Edge gained renewed attention after a significant Medicare-related breakthrough strengthened discussion around its diagnostics expansion strategy and the growing role of precision medicine in g...
Pacific Edge's (ASX:PEB) Medicare LCD for Cxbladder has landed, and the commercial maths have been rewritten Stocks Down Under
other announcement
other announcement
Highlights Pacific Edge expanded its quoted share base through a major placement aimed at strengthening financial flexibility The capital raise reinforced ongoing funding activity across the competitive diagnostics and healthcare technology sector Rising demand for precision diagnostics and personalised healthcare continues reshaping medical testing markets globally Pacific Edge expanded its capital base as diagnostics innovation and healthcare technology transformation continued reshaping me...
other announcement
capital_raise announcement
other announcement
other announcement

other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement